Statins are effective for cardiovascular disease prevention but have recently been associated with an increased risk of new-onset diabetes mellitus. However, until this association is confirmed, treatment discontinuation is not advisable. Lifestyle measures and treatment of risk factors that often cluster with dyslipidemia could ameliorate this potential adverse effect of statins.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Culver, A. L. et al. Statin use and risk of diabetes mellitus in postmenopausal women in the Women's Health Initiative. Arch. Intern. Med. 172, 144–152 (2012).
Sattar, N. et al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet 375, 735–742 (2010).
Preiss, D. et al. Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis. JAMA 305, 2556–2564 (2011).
Athyros, V. G., Tziomalos, K., Karagiannis, A. & Mikhailidis, D. P. Lipid-lowering agents and new onset diabetes mellitus. Expert Opin. Pharmacother. 11, 1965–1970 (2010).
Verdecchia, P. et al. Adverse prognostic significance of new diabetes in treated hypertensive subjects. Hypertension 43, 963–969 (2004).
Athyros, V. G., Tziomalos, K., Karagiannis, A. & Mikhailidis, D. P. Preventing type 2 diabetes mellitus: room for residual risk reduction after lifestyle changes? Curr. Pharm. Des. 16, 3939–3947 (2010).
Athyros, V. G. et al. Long-term impact of multifactorial treatment on new-onset diabetes and related cardiovascular events in metabolic syndrome: a post hoc ATTEMPT analysis. Angiology http://dx.doi.org/10.1177/0003319711421341.
Waters, D. D. et al. Predictors of new-onset diabetes in patients treated with atorvastatin: results from 3 large randomized clinical trials. J. Am. Coll. Cardiol. 57, 1535–1545 (2011).
Karagiannis, A. et al. The effect of antihypertensive agents on insulin sensitivity, lipids and haemostasis. Curr. Vasc. Pharma col. 8, 792–803 (2010).
Neil, H. A. et al.; CARDS Study Investigators. Analysis of efficacy and safety in patients aged 65–75 years at randomization: Collaborative Atorvastatin Diabetes Study (CARDS). Diabetes Care 29, 2378–2384 (2006).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
V. G. Athyros declares no competing interests. D. P. Mikhailidis declares associations with the following companies: Genzyme, MSD (consultant, speaker).
Rights and permissions
About this article
Cite this article
Athyros, V., Mikhailidis, D. Statins and new-onset diabetes mellitus—a matter for debate. Nat Rev Endocrinol 8, 133–134 (2012). https://doi.org/10.1038/nrendo.2012.16
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrendo.2012.16
This article is cited by
-
Prevalence of type 2 diabetes mellitus compared between lean and overweight/obese patients with polycystic ovarian syndrome: a 5-year follow-up study
Archives of Gynecology and Obstetrics (2020)
-
Lipids: a personal view of the past decade
Hormones (2018)
-
Caloric and fat intake in statin users
Nature Reviews Endocrinology (2014)